Literature DB >> 11082139

Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy.

J Mayet1, B Ariff, B Wasan, N Chapman, M Shahi, N R Poulter, P S Sever, R A Foale, S A Thom.   

Abstract

Despite normal indices of left ventricular (LV) chamber function, patients with LV hypertrophy (LVH) due to hypertension are thought to have depressed midwall systolic shortening compared with normotensives. The aims of the present study were (1) to confirm this observation and (2) to assess the effects of antihypertensive therapy that cause regression of LVH on LV systolic function assessed at both the midwall and endocardium. Thirty-eight previously untreated hypertensive subjects with LVH underwent echocardiography and were compared with 38 normotensive control subjects. Comparisons between the group with LVH and the control group revealed no significant differences in cardiac output (4. 32+/-0.23 versus 4.55+/-0.21 L/min), ejection fraction (62.5+/-2% versus 66.4+/-1.07%), or endocardial fractional shortening (34.5+/-1.45% versus 37.0+/-0.82%), but shortening assessed at the midwall was significantly less in the group with LVH (17.9+/-1.11% versus 21.6+/-0.63%, P<0.01). Subsequently, 32 patients with uncontrolled hypertension (24 previously untreated and 8 on existing antihypertensive therapy) underwent treatment with ramipril, with the addition of felodipine and bendrofluazide if required, to reduce blood pressure to <140/90 mm Hg. These 32 patients underwent echocardiography at baseline, after blood pressure control, and after an additional 6 months of tight blood pressure control. Good blood pressure control was achieved after 6 months compared with baseline (143/86+/-2.8/1.4 versus 174/103+/-4.1/1.9 mm Hg; P<0.01) with significant regression of LV mass index (124+/-3.4 versus 145+/-3.8 g/m(2), P<0.01). LV fractional shortening assessed at the midwall improved with regression of LVH (21.9+/-0.84 and 18.7+/-1. 19%, P<0.05), with posttreatment midwall shortening being similar to that of the normal control subjects evaluated in the first study. Hypertensive patients with LVH have depressed midwall systolic shortening despite normal indices of LV chamber function. Regression of LVH after good blood pressure control improved midwall shortening to normal levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082139     DOI: 10.1161/01.hyp.36.5.755

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

Review 1.  Cardiac and vascular pathophysiology in hypertension.

Authors:  Jamil Mayet; Alun Hughes
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

2.  Low-intensity aerobic interval training attenuates pathological left ventricular remodeling and mitochondrial dysfunction in aortic-banded miniature swine.

Authors:  Craig A Emter; Christopher P Baines
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-03       Impact factor: 4.733

3.  Reduced ventricular flow propagation velocity in elite athletes is augmented with the resumption of exercise training.

Authors:  Louise H Naylor; Leonard F Arnolda; Jenny A Deague; David Playford; Antonio Maurogiovanni; Gerard O'Driscoll; Daniel J Green
Journal:  J Physiol       Date:  2005-01-20       Impact factor: 5.182

4.  Percutaneous transluminal angioplasty for peripheral artery disease confers cardiorenal protection.

Authors:  K Eguchi; A Murakami; T Horaguchi; M Kato; H Miyashita; K Kario
Journal:  J Hum Hypertens       Date:  2013-05-02       Impact factor: 3.012

Review 5.  Assessment of left ventricular function in aortic stenosis.

Authors:  Alper Ozkan; Samir Kapadia; Murat Tuzcu; Thomas H Marwick
Journal:  Nat Rev Cardiol       Date:  2011-06-14       Impact factor: 32.419

6.  4-Dimensional light-sheet microscopy to elucidate shear stress modulation of cardiac trabeculation.

Authors:  Juhyun Lee; Peng Fei; René R Sevag Packard; Hanul Kang; Hao Xu; Kyung In Baek; Nelson Jen; Junjie Chen; Hilary Yen; C-C Jay Kuo; Neil C Chi; Chih-Ming Ho; Rongsong Li; Tzung K Hsiai
Journal:  J Clin Invest       Date:  2016-03-28       Impact factor: 14.808

7.  Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats.

Authors:  Oscar H Cingolani; Xiao-Ping Yang; Yun-He Liu; Mirko Villanueva; Nour-Eddine Rhaleb; Oscar A Carretero
Journal:  Hypertension       Date:  2004-03-15       Impact factor: 10.190

Review 8.  Is left ventricular hypertrophy regression important? Does the tool used to detect it matter?

Authors:  Wadih Nadour; Robert W W Biederman
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-08       Impact factor: 3.738

9.  Midwall ejection fraction for assessing systolic performance of the hypertrophic left ventricle.

Authors:  Hisao Yoshikawa; Makoto Suzuki; Go Hashimoto; Yukiko Kusunose; Takenori Otsuka; Masato Nakamura; Kaoru Sugi
Journal:  Cardiovasc Ultrasound       Date:  2012-11-20       Impact factor: 2.062

10.  Cardiac Light-Sheet Fluorescent Microscopy for Multi-Scale and Rapid Imaging of Architecture and Function.

Authors:  Peng Fei; Juhyun Lee; René R Sevag Packard; Konstantina-Ioanna Sereti; Hao Xu; Jianguo Ma; Yichen Ding; Hanul Kang; Harrison Chen; Kevin Sung; Rajan Kulkarni; Reza Ardehali; C-C Jay Kuo; Xiaolei Xu; Chih-Ming Ho; Tzung K Hsiai
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.